Advertisement

Topics

Sorrento Therapeutics acquires Kimberly-Clark's Sofusa drug delivery technology

15:40 EDT 10 Jul 2018 | Elsevier Business Intelligence

Kimberly-Clark Corp. sold its Sofusa lymphatic delivery technology to Sorrento Therapeutics Inc. for an undisclosed sum. ...

Original Article: Sorrento Therapeutics acquires Kimberly-Clark's Sofusa drug delivery technology

NEXT ARTICLE

More From BioPortfolio on "Sorrento Therapeutics acquires Kimberly-Clark's Sofusa drug delivery technology"

Advertisement
Quick Search
Advertisement
Advertisement